strive semaglutide in SubMagna® Strive Meds™ – Doctor Curated

using a nationwide commercial administrative claims database between 2005 and 2021, the use of GLP-1 RAs in patients with T2DM, as compared to that of dipeptidyl peptidase IV (DPP-IV) inhibitors (gliptins), has not been shown to be associated with an increased risk of pulmonary complications after EGD [26]

[,] Although these drugs might show promising results in managing GDM, they are not yet approved for use during pregnancy

If the registry is accurate, this is a materially different pharmacology than the rest of the field, and closer in spirit to a "balanced" metabolic-lever approach than a pure triple agonist

, ,

Pyke C, Knudsen LB (2013)

This is also a recurring monthly subscription rather than a one-time purchase, so any total-cost comparison should account for the billing cycle, not just an advertised starting figure